부산대학교 도서관

Aakash F; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gisriel SD; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.; Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.; Bennett JM; James P Wilmot Cancer Center and Division of Hematopathology, University of Rochester Medical Center, Rochester, NY, USA.; Bejar R; Division of Hematology and Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA, USA.; Bewersdorf JP; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Borate UM; Division of Haematology, the Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Boultwood J; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Brunner AM; Division of Haematology, Massachusetts General Hospital Brigham, Boston, MA, USA.; Buckstein R; Department of Medical Oncology/ Hematology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Carraway H; Leukemia Program, Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.; Churpek JE; Department of Haematology, Oncology, and Palliative Care, Carbone Cancer Center, The University of Wisconsin-Madison, Madison, WI.; Daver NG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD, USA.; Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Health Outcomes Research Unit, Rome, Italy.; Fenaux P; Service d'hématologie, Hôpital Saint-Louis (Assistance Publique Hôpitaux de Paris) and Université de Paris-Cité, Paris, France.; Figueroa ME; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.; Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gore SD; National Cancer Institute, Cancer Therapy Evaluation Program, Rockville, MD, USA.; Greenberg PL; Division of Hematology, Department of Medicine, Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY.; Halene S; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.; Hourigan CS; Virginia Tech, Fralin Biomedical Research Institute, Cancer Research Center.; Kim TK; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.; Kim N; NCI, NIH, Bethesda, Maryland.; Komrokji RS; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Kutchroo V; Brigham and Women's Hospital, Boston, MA, USA.; List AF; Precision BioSciences, Inc., Durham, NC, USA.; Little RF; National Cancer Institute, Cancer Therapy Evaluation Program, Rockville, MD, USA.; Majeti R; Division of Hematology, Department of Medicine, Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Nazha A; Department of Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.; Nimer SD; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.; Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.; Padron E; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.; Platzbecker U; Department of Haematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.; Della Porta MG; IRCCS Humanitas Research Hospital, Milan, Italy and Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Roboz GJ; Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY, USA.; Sallman DA; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Santini V; Myelodysplastic syndromes Unit, Department of Experimental and Clinical Medicine, Haematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy.; Sanz G; Health Research Institute La Fe, Valencia, Spain; Hospital Universitario y Politécnico La Fe, Valencia, Spain; CIBERONC, IS Carlos III, Madrid, Spain.; Savona MR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.; Sekeres MA; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.; Stahl M; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Starczynowski DT; Cincinnati Children's Hospital, Cincinnati, OH.; Steensma DP; David Steensma LLC, Cambridge, Massachusetts 02139, USA.; Taylor J; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.; Abdel-Wahab O; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Wei AH; Department of Haematology, Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research and University of Melbourne, Victoria, Australia.; Zhuoer X; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Xu ML; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.; Hasserjian RP; Department of Pathology, Massachusetts General Hospital Brigham, Boston, MA, USA.; Loghavi S; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: Sloghavi@mdanderson.org.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE

Campo E; Laboratory of Pathology, Hospital Clinic, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Dierickx D; Department of Hematology, University Hospitals Leuven, Leuven, Belgium.; Dirnhofer S; Institute of Medical Genetics & Pathology, University Hospital Basel, Basel, Switzerland.; Dunleavy K; Department of Hematology, Medstar Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC.; Gaulard P; Department of Pathology, University Hospital Henri Mondor, Institut National de la Santé et de la Recherche Médicale U955, Université Paris-Est, Créteil, France.; Hasserjian RP; Department of Pathology, WRN244, Massachusetts General Hospital, Boston, MA.; Jaffe ES; Lab of Pathology, CCR, NCI, Bethesda, MD.; Kim WS; Division of Hematology-Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea.; King RL; Mayo Clinic, Rochester, MN.; Lim MS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Ott G; Department of Clinical Pathology, Robert-Bosch-Krankenhaus and Dr Margarete Fischer-Bosch Institute for Clinical Pharmacology, Stuttgart, Germany.; Piris MA; Pathology Service, Fundación Jiménez Díaz, Madrid, Spain.; Salles G; Department of Medicine Lymphoma Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine College, New York, NY.; Siebert R; Professor of Human Genetics, Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Crane GM; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, US.; Geyer JT; Department of Pathology, Weill Cornell Medicine, New York, NY, US.; Thakral B; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.; Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.; Wool GD; Department of Pathology, University of Chicago, Chicago, IL, US.; Li KD; Department of Pathology, University of Utah, Salt Lake City, UT, US.; Davis AR; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, US.; Boiocchi L; Department of Pathology, Massachusetts General Hospital, Boston, MA, US.; Bosler D; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, US.; Bueso-Ramos CE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.; Arber DA; Department of Pathology, University of Chicago, Chicago, IL, US.; George TI; Department of Pathology, University of Utah, Salt Lake City, UT, US.; Bagg A; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, US.; Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA, US.; Orazi A; Department of Pathology, Texas Tech University Health Science Center, El Paso, TX, US.; Hsi ED; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, US.; Rogers HJ; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, US.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0370470 Publication Model: Print Cited Medium: Internet ISSN: 1943-7722 (Electronic) Linking ISSN: 00029173 NLM ISO Abbreviation: Am J Clin Pathol Subsets: MEDLINE

Döhner H; University Hospital Ulm, Ulm, Germany.; DiNardo CD; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Wei AH; Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Löwenberg B; Department of Hematology, Erasmus MC, Rotterdam, The Netherlands, Rotterdam, Netherlands.; Appelbaum F; Fred Hutchinson Cancer Center, Seattle, WA, USA, Seattle, Washington, United States.; Craddock C; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.; Dombret H; Université Paris Cité, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.; Ebert BL; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Fenaux P; hôpital St Louis, Paris, PARIS, France.; Godley LA; Northwestern University, Chicago, Illinois, United States.; Hasserjian RP; Massachusetts General Hospital, Boston, Massachusetts, United States.; Larson RA; University of Chicago, Chicago, Illinois, United States.; Levine RL; Memorial Sloan-Kettering Cancer Center, New York, New York, United States.; Miyazaki Y; Atomic Bomb Disease Institute, Ngasaki University, Nagasaki, Japan.; Niederwieser D; University Leipzig, Leipzig, Germany.; Ossenkoppele GJ; Amsterdam UMC, location VUmc, Amsterdam, Netherlands.; Röllig C; Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany, Dresden, Germany.; Sierra J; Hospital Santa Creu i Sant Pau, Barcelona, Spain.; Stein EM; Memorial Sloan Kettering Cancer Center, New York, New York, United States.; Tallman MS; Memorial Sloan Kettering Cancer Center, Highland Park, Illinois, United States.; Tien HF; National Taiwan University Hospital, Taipei, Taiwan.; Wang J; State Key Laboratory of Experimental Hematology, National Clinical Research Center of Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Wierzbowska A; Medical University of Lodz, Lodz, Poland.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Xiao W; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. xiaow@mskcc.org.; Nardi V; Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA.; Stein E; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Hasserjian RP; Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA. rhasserjian@mgh.harvard.edu.

Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

Bernard E; Gustave Roussy, France.; Hasserjian RP; Massachusetts General Hospital, Boston, Massachusetts, United States.; Greenberg PL; Stanford University Cancer Institute, Stanford, California, United States.; Arango Ossa JE; Memorial Sloan Kettering Cancer Center, New York, New York, United States.; Creignou M; Karolinska Institutet, Huddinge, Sweden.; Tuechler H; Independent researcher.; Gutiérrez-Abril J; MSKCC, NYC, New York, United States.; Domenico D; Memorial Sloan Kettering Cancer Center, New York, New York, United States.; Medina-Martinez JS; Memorial Sloan Kettering Cancer Center, New york, New York, United States.; Levine MF; Memorial Sloan Kettering, New York, New York, United States.; Liosis K; Memorial Sloan Kettering Cancer Center, New york, New York, United States.; Farnoud N; Memorial Sloan Kettering Cancer Center, New York, New York, United States.; Sirenko M; Memorial Sloan Kettering Cancer Center, New York City, New York, United States.; Jädersten M; Karolinska Institutet, Stockholm, Sweden.; Germing U; Heinrich-Heine-University, Duesseldorf, Germany.; Sanz GF; Hospital Universitario y Politécnico La Fe, Valencia, Spain, Health Research Institute La Fe, Valencia, Spain, and CIBERONC, Instituto de Salud Carlos III, Madrid, Spain, Valencia, Spain.; Van de Loosdrecht AA; VU University Medical Center, Amsterdam, Netherlands.; Nannya Y; The University of Tokyo, Tokyo, Japan.; Kosmider O; Hopital Cochin, Paris, France.; Follo MY; University of Bologna, Bologna, Italy.; Thol FR; Hannover Medical School, Hannover, Germany.; Zamora L; Hematología. ICO Badalona - HGTiP. Institut d'Investigació contra la Leucèmia Josep Carreras, Badalona, Spain.; Pinheiro RF; Federal University of Ceara, Fortaleza, Brazil.; Pellagatti A; University of Oxford, Oxford, United Kingdom.; Elias HK; National Institutes of Health, Bethesda, Maryland, United States.; Haase DT; University Medical Center, Goettingen, Germany.; Ganster C; University of Goettingen, Göttingen, Germany.; Ades L; Hopital Saint Louis, Paris, France.; Tobiasson M; Karolinska Institute; Karolinska University Hospital, Stockholm, Sweden.; Palomo L; Institut Catala d'Oncololgia, Badalona, Spain.; Della Porta MG; IRCCS Humanitas Research Hospital & Humanitas University, Rozzano - Milan, Italy.; Fenaux P; hôpital St Louis, Paris, PARIS, France.; Belickova M; The Institute of Hematology and Blood Transfusion, Prague, Czech Republic.; Savona MR; Vanderbilt University School of Medicine, Nashville, Tennessee, United States.; Klimek V; Syros Pharmaceuticals, Cambridge, Massachusetts, United States.; Santos FPS; Hospital Israelita Albert Einstein, Sao Paulo, Brazil.; Boultwood J; University of Oxford, Oxford, United Kingdom.; Kotsianidis I; DUTH, ALEXPOLIS, Greece.; Santini V; MDS Unit, University of Florence, Florence, Italy.; Sole F; Institut de Recerca contra la Leucemia Josep Carreras. Barcelona, Spain, Badalona, Spain.; Platzbecker U; University Hospital Leipzig, Department of Hematology and Cell Therapy, Leipzig, Germany.; Heuser M; Hannover Medical School, Hannover, Germany.; Valent P; Medical University of Vienna, Vienna, Austria.; Finelli C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy, Bologna, Italy.; Voso MT; Tor Vergata, Rome, Italy.; Shih LY; Chang Gung Memorial Hospital-Linkou, Taipei, Taiwan.; Fontenay M; Université de Paris, AP-HP Hôpital Cochin, Paris, France.; Jansen JH; UMC-St Radboud, Nijmegen, Netherlands.; Cervera J; Hospital Universitario La Fe, Valencia, Spain.; Gattermann N; Heinrich Heine University Düsseldorf, Duesseldorf, Germany.; Ebert BL; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Bejar R; University of California, San Diego, La Jolla, California, United States.; Malcovati L; University of Pavia, Pavia, Italy.; Ogawa S; Kyoto University, Kyoto, Japan.; Cazzola M; University of Pavia, Pavia, Italy.; Hellstrom-Lindberg ES; Karolinska Institutet, Stockholm, Sweden.; Papaemmanuil E; MSKCC, NYC, United Kingdom.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Menke JR; Division of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States.; Aypar U; Division of Cytogenetics, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Bangs CD; Division of Cytogenetics, Department of Pathology, Stanford University, Stanford, CA, United States.; Cook SL; Department of Laboratory Medicine, San Francisco Veterans Administration Health Care System, San Francisco, CA, United States.; Gupta S; Division of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States.; Division of Hematopathology, Department of Laboratory Medicine, San Francisco, CA, United States.; Hasserjian RP; Division of Hematopathology, Department of Pathology, Massachusetts General Hospital, Boston, MA, United States.; Kong CS; Division of Cytopathology, Department of Pathology, Stanford University, Stanford, CA, United States.; Lin O; Division of Cytopathology, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Long SR; Division of Cytopathology, Department of Pathology, University of California, San Francisco, San Francisco, CA, United States.; Ly A; Division of Cytopathology, Department of Pathology, Massachusetts General Hospital, Boston, MA, United States.; Menke JAS; Senior Backend Engineer, Big Nerd Ranch, Atlanta, GA, United States.; Natkunam Y; Division of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States.; Ruiz-Cordero R; Division of Cytopathology, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Divisons of Molecular Genetic Pathology, Cytopathology, and Hematopathology, Department of Pathology and Laboratory Medicine, University of Miami, Miami, FL, United States.; Spiteri E; Division of Cytogenetics, Department of Pathology, Stanford University, Stanford, CA, United States.; Ye J; Division of Cytopathology, Department of Pathology, University of California, San Francisco, San Francisco, CA, United States.; Zadeh SL; Division of Cytopathology, Department of Pathology, University of Virginia, Charlottesville, VA, United States.; Gratzinger DA; Division of Hematopathology, Department of Pathology, Stanford University, Stanford, CA, United States.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Yin CC; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX. cyin@mdanderson.org.; Tam W; Division of Hematopathology, Department of Pathology and Laboratory Medicine, Donald and Barbara Zucker School of Medicine, Hofstra/Northwell, Greenvale, NY.; Walker SM; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA.; Kaur A; Department of Pathology, University of Chicago, Chicago, IL.; Ouseph MM; Department of Pathology and Laboratory Medicine, Weill Cornell Medical Center, New York, NY.; Xie W; Department of Pathology and Laboratory Medicine, Oregon Health and Science University, Portland, OR.; K Weinberg O; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX.; Li P; Department of Pathology, University of Utah, Salt Lake City, UT.; Zuo Z; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX.; Routbort MJ; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX.; Chen S; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA.; Medeiros LJ; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX.; George TI; Department of Pathology, University of Utah, Salt Lake City, UT.; Orazi A; Department of Pathology, Texas Tech University, El Paso, TX.; Arber DA; Department of Pathology, University of Chicago, Chicago, IL.; Bagg A; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA.; Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA.; Wang SA; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX. Swang5@mdanderson.org.

Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Sarro R; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland; Institute of Pathology Ente Ospedaliero Cantonale (EOC), Locarno, Switzerland.; Bisig B; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.; Guey B; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.; Missiaglia E; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.; Cairoli A; Service of Haematology, Department of Oncology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.; Omoumi P; Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.; Letovanec I; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland; Department of Pathology, Central Institute, Valais Hospital, Sion, Switzerland.; Ferry JA; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Hasserjian RP; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; de Leval L; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland. Electronic address: Laurence.deLeval@chuv.ch.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE

Sadigh S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.; Hergott CB; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Lane AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lovitch SB; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Lucas F; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Morgan EA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Pinkus GS; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Pozdnyakova O; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Shanmugam V; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Tsai HK; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Winer ES; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Zemmour D; Department of Pathology, The University of Chicago, Chicago, Illinois.; Kim AS; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Now with Department of Pathology, University of Michigan, Ann Arbor, Michigan. Electronic address: kimannet@med.umich.edu.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE